Who owns Verona Pharma Plc ads?
- Ticker: VRNA
- CUSIP Number: 925050106
Tip: Access positions for across all investors
Analyze quarterly positions in Verona Pharma Plc ads with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Verona Pharma Plc ads stock
Who bought or sold Verona Pharma Plc ads this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 6.3M | $102M | 0% | Mar 2024 |
|
| NEA Management Company | 5.1M | $90M | 0% | Mar 2024 |
|
| Wellington Management Company | 3.8M | $75M | -15% | Dec 2023 |
|
| Perceptive Advisors | 3.8M | $61M | -3% | Mar 2024 |
|
| Vivo Capital | 3.6M | $58M | -15% | Mar 2024 |
|
| OrbiMed Advisors | 3.4M | $55M | -10% | Mar 2024 |
|
| Frazier Life Sciences Management | 3.0M | $49M | 0% | Mar 2024 |
|
| Federated Investors | 2.5M | $50M | 0% | Dec 2023 |
|
| Carlyle | 2.5M | $39M | 0% | Mar 2024 |
|
| Octagon Capital Advisors | 2.4M | $38M | 0% | Mar 2024 |
|
| Eventide Asset Management | 2.2M | $35M | 59% | Mar 2024 |
|
| Henderson Group | 2.0M | $33M | 13% | Mar 2024 |
|
| Maverick Capital | 1.8M | $29M | 7% | Mar 2024 |
|
| FMR | 1.7M | $28M | -75% | Mar 2024 |
|
| Jennison Associates | 1.6M | $26M | 1% | Mar 2024 |
|
| Caligan Partners | 1.3M | $21M | 608% | Mar 2024 |
|
| Bellevue Group | 1.1M | $18M | 36% | Mar 2024 |
|
| Aisling Capital Management | 1.1M | $22M | 0% | Dec 2023 |
|
| First Turn Management | 973k | $16M | -19% | Mar 2024 |
|
| Laurion Capital Management | 882k | $14M | 51% | Mar 2024 |
|
| Woodline Partners | 840k | $14M | 43% | Mar 2024 |
|
| Rice Hall James & Associates | 676k | $11M | 44% | Mar 2024 |
|
| Boothbay Fund Management | 639k | $10M | 1037% | Mar 2024 |
|
| American Century Companies | 561k | $9.0M | 100% | Mar 2024 |
|
| Parkman Healthcare Partners | 530k | $8.5M | 27% | Mar 2024 |
|
| Millennium Management | 504k | $8.1M | 31% | Mar 2024 |
|
| BlackRock | 382k | $6.1M | 14% | Mar 2024 |
|
| Ikarian Capital | 375k | $6.0M | 2% | Mar 2024 |
|
| Samsara BioCapital | 348k | $5.6M | 0% | Mar 2024 |
|
| Morgan Stanley | 333k | $5.4M | 350% | Mar 2024 |
|
| Moody Aldrich Partners | 315k | $5.1M | -2% | Mar 2024 |
|
| Axa | 278k | $4.5M | -2% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 260k | $4.2M | -14% | Mar 2024 |
|
| Superstring Capital Management | 259k | $4.2M | 109% | Mar 2024 |
|
| ClearBridge Advisors | 256k | $4.1M | 3% | Mar 2024 |
|
| Rosalind Advisors | 250k | $4.0M | 0% | Mar 2024 |
|
| Neuberger Berman Group | 214k | $3.4M | 100% | Mar 2024 |
|
| Knoll Capital Management | 200k | $3.2M | 0% | Mar 2024 |
|
| Citadel Advisors | 196k | $3.1M | 126% | Mar 2024 |
|
| Adage Capital Partners GP | 175k | $2.8M | -59% | Mar 2024 |
|
| Nicholas Investments Partners | 169k | $3.4M | -85% | Dec 2023 |
|
| 1492 Capital Management | 164k | $2.6M | -1% | Mar 2024 |
|
| Two Sigma Investments | 142k | $2.3M | 200% | Mar 2024 |
|
| Artia Global Partners | 131k | $2.1M | 0% | Mar 2024 |
|
| Bank of America Corporation | 128k | $2.1M | 53% | Mar 2024 |
|
| Kennedy Capital Management | 123k | $2.0M | -26% | Mar 2024 |
|
| Polar Securities | 97k | $1.6M | 0% | Mar 2024 |
|
| Goldman Sachs Group | 93k | $1.5M | 132% | Mar 2024 |
|
| Legal & General Group | 80k | $1.3M | -1% | Mar 2024 |
|
| Susquehanna International | 77k | $1.2M | 29% | Mar 2024 |
|
| Sei Investments | 74k | $1.2M | 58% | Mar 2024 |
|
| Hennion & Walsh Asset Management | 67k | $1.1M | 71% | Mar 2024 |
|
| Geode Capital Management | 65k | $1.1M | 25% | Mar 2024 |
|
| Wells Fargo & Company | 60k | $969k | 243% | Mar 2024 |
|
| AlphaCentric Advisors | 56k | $901k | 0% | Mar 2024 |
|
| ALPS Advisors | 54k | $1.1M | -8% | Dec 2023 |
|
| Jane Street | 38k | $613k | 132% | Mar 2024 |
|
| UBS O'Connor | 36k | $584k | 100% | Mar 2024 |
|
| CM Management | 35k | $563k | 100% | Mar 2024 |
|
| Glenmede Trust Company | 34k | $554k | -12% | Mar 2024 |
|
| HighVista Strategies | 32k | $522k | 9% | Mar 2024 |
|
| Bank of New York Mellon | 30k | $478k | -22% | Mar 2024 |
|
| Simplex Trading | 28k | $445k | -53% | Mar 2024 |
|
| Envestnet Asset Management | 28k | $446k | 0% | Mar 2024 |
|
| PFG Investments | 27k | $428k | 49% | Mar 2024 |
|
| Capstone Investment Advisors | 26k | $412k | 100% | Mar 2024 |
|
| Us Bancorp | 24k | $383k | -43% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 23k | $377k | 1054% | Mar 2024 |
|
| China Universal Asset Management | 20k | $325k | 36% | Mar 2024 |
|
| DekaBank Deutsche Girozentrale | 20k | $322k | 0% | Mar 2024 |
|
| Deschutes Portfolio Strategy | 19k | $312k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 18k | $284k | 38% | Mar 2024 |
|
| Rathbones Brothers | 16k | $257k | 0% | Mar 2024 |
|
| Ing Investment Management | 16k | $257k | 0% | Mar 2024 |
|
| Orion Portfolio Solutions | 15k | $237k | -12% | Mar 2024 |
|
| Cubist Systematic Strategies | 14k | $220k | 100% | Mar 2024 |
|
| Group One Trading | 13k | $204k | 5% | Mar 2024 |
|
| Centiva Capital | 12k | $196k | 100% | Mar 2024 |
|
| Jump Financial | 11k | $226k | 100% | Dec 2023 |
|
| HighTower Advisors | 11k | $169k | 0% | Mar 2024 |
|
| Quarry | 5.5k | $89k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 2.6k | $41k | -18% | Mar 2024 |
|
| Quantbot Technologies | 2.5k | $40k | 209% | Mar 2024 |
|
| Cape Investment Advisory | 2.0k | $40k | 100% | Dec 2023 |
|
| UBS Group | 1.8k | $30k | -9% | Mar 2024 |
|
| Royal Bank of Canada | 1.6k | $27k | 4% | Mar 2024 |
|
| Winthrop Capital Management | 1.2k | $20k | 100% | Mar 2024 |
|
| Cutler | 1.2k | $18k | -15% | Mar 2024 |
|
| Plante Moran Financial Advisors | 892.00 | $14k | 0% | Mar 2024 |
|
| Tower Research Capital | 700.00 | $11k | 64% | Mar 2024 |
|
| Financial Freedom | 545.00 | $8.8k | 100% | Mar 2024 |
|
| Main Street Group | 500.00 | $9.9k | 100% | Dec 2023 |
|
| Rhumbline Advisers | 498.00 | $8.0k | 80% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 400.00 | $6.4k | 100% | Mar 2024 |
|
| GAMMA Investing | 366.00 | $5.9k | 2053% | Mar 2024 |
|
| EverSource Wealth Advisors | 295.00 | $5.9k | 0% | Mar 2024 |
|
| Citigroup | 247.00 | $4.0k | -80% | Mar 2024 |
|
| Daiwa Securities Group | 244.00 | $4.0k | 0% | Mar 2024 |
|
| Private Trust Co Na | 117.00 | $1.9k | 0% | Mar 2024 |
|
| Global Retirement Partners | 50.00 | $805.000000 | 0% | Mar 2024 |
|
| Bell Investment Advisors | 31.00 | $499.000800 | 0% | Mar 2024 |
|
| Principal Securities | 26.00 | $417.999400 | 0% | Mar 2024 |
|
| Zurcher Kantonalbank | 2.00 | $32.000000 | -100% | Mar 2024 |
|
Who sold out of Verona Pharma Plc ads?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Avidity Partners Management | Dec 2023 | 781k | $16M |
| Tri Locum Partners | Dec 2023 | 293k | $5.8M |
| Walleye Trading Advisors | Dec 2023 | 257k | $5.1M |
| Caption Management | Dec 2023 | 172k | $3.4M |
| Campbell & Co. Investment Adviser | Sep 2023 | 50k | $815k |
| Marshall Wace | Dec 2023 | 40k | $800k |
| D.A. Davidson & Co. | Dec 2023 | 33k | $664k |
| New York State Common Retirement Fund | Dec 2023 | 30k | $590k |
| Legato Capital Management | Dec 2023 | 24k | $484k |
| Walleye Trading | Dec 2023 | 21k | $419k |
| Parkwood | Dec 2023 | 14k | $277k |
| Larson Financial Group | Dec 2023 | 25.00 | $497.000000 |